These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 26523295)

  • 1. The association and aggregation of the metamorphic chemokine lymphotactin with fondaparinux: from nm molecular complexes to μm molecular assemblies.
    Harvey SR; MacPhee CE; Volkman BF; Barran PE
    Chem Commun (Camb); 2016 Jan; 52(2):394-7. PubMed ID: 26523295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homology modeling and molecular dynamics simulations of lymphotactin.
    Buyong ; Xiong J; Lubkowski J; Nussinov R
    Protein Sci; 2000 Nov; 9(11):2192-9. PubMed ID: 11152129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphotactin: how a protein can adopt two folds.
    Camilloni C; Sutto L
    J Chem Phys; 2009 Dec; 131(24):245105. PubMed ID: 20059117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin.
    Peterson FC; Elgin ES; Nelson TJ; Zhang F; Hoeger TJ; Linhardt RJ; Volkman BF
    J Biol Chem; 2004 Mar; 279(13):12598-604. PubMed ID: 14707146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomeric solution structure of the prototypical 'C' chemokine lymphotactin.
    Kuloglu ES; McCaslin DR; Kitabwalla M; Pauza CD; Markley JL; Volkman BF
    Biochemistry; 2001 Oct; 40(42):12486-96. PubMed ID: 11601972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation.
    Fox JC; Tyler RC; Guzzo C; Tuinstra RL; Peterson FC; Lusso P; Volkman BF
    ACS Chem Biol; 2015 Nov; 10(11):2580-8. PubMed ID: 26302421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the dynamic conformations of the metamorphic protein lymphotactin.
    Harvey SR; Porrini M; Konijnenberg A; Clarke DJ; Tyler RC; Langridge-Smith PR; MacPhee CE; Volkman BF; Barran PE
    J Phys Chem B; 2014 Oct; 118(43):12348-59. PubMed ID: 25259958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An activation-responsive element in single C motif-1/lymphotactin promoter is a site of constitutive and inducible DNA-protein interactions involving nuclear factor of activated T cell.
    Yoshida T; Ishikawa I; Ono Y; Imai T; Suzuki R; Yoshie O
    J Immunol; 1999 Sep; 163(6):3295-303. PubMed ID: 10477599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interconversion between two unrelated protein folds in the lymphotactin native state.
    Tuinstra RL; Peterson FC; Kutlesa S; Elgin ES; Kron MA; Volkman BF
    Proc Natl Acad Sci U S A; 2008 Apr; 105(13):5057-62. PubMed ID: 18364395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An engineered second disulfide bond restricts lymphotactin/XCL1 to a chemokine-like conformation with XCR1 agonist activity.
    Tuinstra RL; Peterson FC; Elgin ES; Pelzek AJ; Volkman BF
    Biochemistry; 2007 Mar; 46(10):2564-73. PubMed ID: 17302442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotactin: a new class of chemokine.
    Hedrick JA; Zlotnik A
    Methods Enzymol; 1997; 287():206-15. PubMed ID: 9330324
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily.
    Fox JC; Nakayama T; Tyler RC; Sander TL; Yoshie O; Volkman BF
    Cytokine; 2015 Feb; 71(2):302-11. PubMed ID: 25497737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron capture dissociation and drift tube ion mobility-mass spectrometry coupled with site directed mutations provide insights into the conformational diversity of a metamorphic protein.
    Harvey SR; Porrini M; Tyler RC; MacPhee CE; Volkman BF; Barran PE
    Phys Chem Chem Phys; 2015 Apr; 17(16):10538-50. PubMed ID: 25805055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions.
    Kuloğlu ES; McCaslin DR; Markley JL; Volkman BF
    J Biol Chem; 2002 May; 277(20):17863-70. PubMed ID: 11889129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic Evolution of a Metamorphic Protein: A Theoretical-Computational Study of Human Lymphotactin.
    Zanetti-Polzi L; Daidone I; Iacobucci C; Amadei A
    Protein J; 2023 Jun; 42(3):219-228. PubMed ID: 37233895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of single C motif-1/lymphotactin receptor XCR1.
    Yoshida T; Imai T; Kakizaki M; Nishimura M; Takagi S; Yoshie O
    J Biol Chem; 1998 Jun; 273(26):16551-4. PubMed ID: 9632725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine lymphotactin: gene structure, post-translational modification and inhibition of expression by CD28 costimulation.
    Hautamaa D; Merica R; Chen Z; Jenkins MK
    Cytokine; 1997 Jun; 9(6):375-82. PubMed ID: 9199871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical synthesis of lymphotactin: a glycosylated chemokine with a C-terminal mucin-like domain.
    Marcaurelle LA; Mizoue LS; Wilken J; Oldham L; Kent SB; Handel TM; Bertozzi CR
    Chemistry; 2001 Mar; 7(5):1129-32. PubMed ID: 11303872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphotactin.
    Hedrick JA; Zlotnik A
    Clin Immunol Immunopathol; 1998 Jun; 87(3):218-22. PubMed ID: 9646830
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemistry. Metamorphic proteins.
    Murzin AG
    Science; 2008 Jun; 320(5884):1725-6. PubMed ID: 18583598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.